PETALING JAYA, Sept 14 — Sharp Corporation has developed a device equipped with Plasmacluster technology that they claim can effectively reduce the airborne novel coronavirus particles.
A collaborative effort, the Plasmacluster technology is the result of the collaborative effort between researchers from the National Research Centre for the Control and Prevention of Infectious Diseases, Nagasaki University and Shimane University’s faculty of medicine.
The brand prides itself on the effectiveness of its Plasmacluster technology from 2004 where the technology inactivated the feline coronavirus (FCoV).
In 2005, Sharp demonstrated its effectiveness of its Plasmacluster technology against the original SARS coronavirus which caused the outbreak from 2002 till 2004 that is genetically similar to the novel coronavirus (SARS-CoV-2).
The brand has promoted academic marketing since 2000 to demonstrate the effectiveness